Skip to main content

Table 3 Multivariate Cox porportional hazard model for virological relapse with off-therapy HBsAg level as a time-varying variable

From: Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy

Variables

Adjusted HR

95% CI

P

Time-varying HBsAg level, log IU/mL

2.10

1.45, 3.04

<0.0001

Male sex

1.33

0.58, 3.05

0.49

EOT age, year

1.04

1.02, 1.06

0.0005

EOT ALT, U/L

1.02

1.01, 1.02

<0.0001

EOT AFP, ng/mL

1.06

0.96, 1.16

0.24

EOT anti-HBe-seropositive

0.46

0.16, 1.29

0.14

Pretreatment viral DNA, log IU/mL

1.06

0.90, 1.25

0.52

Pretreatment HBeAg-positive

2.58

0.53, 12.50

0.24

Pretreatment anti-HBe-positive

4.02

0.88, 18.3

0.07

  1. Notes. AFP alpha-fetoprotein, ALT Alanine transaminase, CI confidence interval, EOT end-of-therapy, HBeAg hepatitis B e antigen, HBsAg hepatitis B surface antigen, HR hazard ratio